| Date | Form | Description | Docs | XBRL | Pages |
| 03/10/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 01/21/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/16/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/15/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/14/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology
Read More...Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy
Read More...Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
Read More...